This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2000;284:2582-2583.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chicago—Tissue engineering, only a theoretical possibility less than a decade ago, is moving closer to becoming a real discipline.

Researchers who presented their findings at the American College of Surgeons Clinical Congress here last month said they are making advances in engineering tissue for replacing heart valves and blood vessels and for treating ovarian cancer.

RAPID DEVELOPMENT

"This is perhaps the most rapidly developing, and potentially the most important, topic related to organ replacement and organ repair," said Dana K. Andersen, MD, professor and vice chair of the Department of Surgery at Yale University School of Medicine. "We're trying to focus attention on the science of directed growth and development of tissues and organs—which can be implanted into the patient—using the strategy of in vitro development."

Andersen charted the beginning of tissue engineering as an academic discipline from an article published in 1993 by Robert Langer, ScD, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heart Valve Tissue Engineering
Vesely
Circ. Res. 2005;97:743-755.
ABSTRACT | FULL TEXT